TrialBritish journal of clinical pharmacology2025
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.
Andrea Kuemmerle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.